Evidence map›Paper›PMID 31469829›Full record

ArticlePLoS genetics2019

GRAM: A GeneRAlized Model to predict the molecular effect of a non-coding variant in a cell-type specific manner.

Shaoke Lou, Kellie A Cotter, Tianxiao Li, Jin Liang, Hussein Mohsen, Jason Liu, Jing Zhang, Sandra Cohen, Jinrui Xu, Haiyuan Yu and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Shaoke LouProgram in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut, United States of America.ORCID 0000-0002-2626-5897
Kellie A CotterDepartment for BioMedical Research, University of Bern, CH, Bern, Switzerland.ORCID 0000-0002-2574-815X
Tianxiao LiProgram in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut, United States of America.ORCID 0000-0002-9147-7511
Jin LiangWeill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, United States of America.
Hussein MohsenProgram in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut, United States of America.ORCID 0000-0002-6263-8865
Jason LiuProgram in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut, United States of America.
Jing ZhangProgram in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut, United States of America.
Sandra CohenDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, Cornell University, New York, New York, United States of America.
Jinrui XuProgram in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut, United States of America.ORCID 0000-0003-1944-2821
Haiyuan YuWeill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, United States of America.
Mark A RubinDepartment for BioMedical Research, University of Bern, CH, Bern, Switzerland.
Mark GersteinProgram in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut, United States of America.
Yale University · USCornell University · USUniversity of Bern · CH

Funding

High-throughput functional characterization of human enhancersUM1HG009393 · NHGRI · CORNELL UNIVERSITY · PI LIS, JOHN T, YU, HAIYUAN · 2017 to 2021
$4.1M
Prioritizing rare variants associated with cancer using non-coding annotationR01HG008126 · NHGRI · YALE UNIVERSITY · PI GERSTEIN, MARK BENDER · 2016 to 2018
$2.4M
NHGRI NIH HHS R01 HG008126
6 · The paper itself

Abstract

There has been much effort to prioritize genomic variants with respect to their impact on "function". However, function is often not precisely defined: sometimes it is the disease association of a variant; on other occasions, it reflects a molecular effect on transcription or epigenetics. Here, we coupled multiple genomic predictors to build GRAM, a GeneRAlized Model, to predict a well-defined experimental target: the expression-modulating effect of a non-coding variant on its associated gene, in a transferable, cell-specific manner. Firstly, we performed feature engineering: using LASSO, a regularized linear model, we found transcription factor (TF) binding most predictive, especially for TFs that are hubs in the regulatory network; in contrast, evolutionary conservation, a popular feature in many other variant-impact predictors, has almost no contribution. Moreover, TF binding inferred from in vitro SELEX is as effective as that from in vivo ChIP-Seq. Second, we implemented GRAM integrating only SELEX features and expression profiles; thus, the program combines a universal regulatory score with an easily obtainable modifier reflecting the particular cell type. We benchmarked GRAM on large-scale MPRA datasets, achieving AUROC scores of 0.72 in GM12878 and 0.66 in a multi-cell line dataset. We then evaluated the performance of GRAM on targeted regions using luciferase assays in the MCF7 and K562 cell lines. We noted that changing the insertion position of the construct relative to the reporter gene gave very different results, highlighting the importance of carefully defining the exact prediction target of the model. Finally, we illustrated the utility of GRAM in fine-mapping causal variants and developed a practical software pipeline to carry this out. In particular, we demonstrated in specific examples how the pipeline could pinpoint variants that directly modulate gene expression within a larger linkage-disequilibrium block associated with a phenotype of interest (e.g., for an eQTL).

Indexed as

AlgorithmsBinding SitesComputer SimulationForecastingGene Expression RegulationGenetic VariationGenomicsHumansLinkage DisequilibriumModels, GeneticProtein BindingQuantitative Trait LociSequence Analysis, DNASoftwareTranscription FactorsTranscription Factors

Identifiers

PMID31469829
PMCPMC6742416
OpenAlexW2971104791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.